As healthcare professionals, it is crucial to deepen our understanding of neurodegenerative disorders. One such condition that requires our attention is Parkinson's disease, a progressive disorder of the nervous system that affects movement. This article aims to provide a comprehensive overview of Parkinson's disease.
Parkinson's disease is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, resulting in a deficiency of the neurotransmitter dopamine. This deficiency is primarily responsible for the motor symptoms associated with the disease. The exact cause of this neuronal death is still unknown, but it is believed to involve both genetic and environmental factors.
The cardinal symptoms of Parkinson's disease include bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are also common and can significantly impact the quality of life of these patients.
Diagnosis of Parkinson's disease is primarily clinical, based on the presence of characteristic motor symptoms and the response to dopaminergic therapy. Neuroimaging studies, such as DaTscan, can support the diagnosis, but are not typically necessary.
While there is no cure for Parkinson's disease, several treatment options can help manage symptoms. These include pharmacological treatments, such as levodopa and dopamine agonists, and non-pharmacological interventions, such as physical therapy. In advanced cases, deep brain stimulation may be considered.
As healthcare professionals, our role in managing Parkinson's disease is not just to treat motor symptoms, but also to address the non-motor symptoms and improve the overall quality of life of our patients. By deepening our understanding of this complex disorder, we can provide better care for our patients and contribute to the ongoing research in this field.
1.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
2.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
5.
Early breast cancer detection may be possible with a wearable ultrasound scanner.
1.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
2.
Tumor Evolution: Signaling, Plasticity, and Intratumor Heterogeneity in Cancer
3.
Essential Perspectives in Hematology and Patient Outcomes
4.
Decoding Hamartomas: Understanding Their Causes and Symptoms
5.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
5.
Signs and Symptoms of Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation